These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7488337)

  • 1. Soluble interleukin-2 receptor as a clinical parameter for nasopharyngeal carcinoma.
    Hsu MM; Chen YJ; Chang YL; Ko JY; Sheen TS
    Asian Pac J Allergy Immunol; 1995 Jun; 13(1):1-4. PubMed ID: 7488337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble interleukin-2 receptors in patients with nasopharyngeal carcinoma.
    Lai KN; Ho S; Leung JC; Tsao SY
    Cancer; 1991 Apr; 67(8):2180-5. PubMed ID: 1848475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of soluble interleukin-2 receptor in monitoring disease relapse in patients with nasopharyngeal cancer.
    Wu LJ; Chen KY; Chi KH; Chen SY; Liang MJ; Shiau CY; Wang LW; Liu YM; Chow KC; Yen SH
    Jpn J Clin Oncol; 1998 Dec; 28(12):729-32. PubMed ID: 9879289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of measuring levels of tumor necrosis factor-alpha and soluble interleukin-2 receptor in nasopharyngeal carcinoma.
    Hsiao SH; Lee MS; Lin HY; Su YC; Ho HC; Hwang JH; Lee CC; Hung SK
    Acta Otolaryngol; 2009 Dec; 129(12):1519-23. PubMed ID: 19922107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated serum levels of neopterin and soluble interleukin-2 receptor in patients with ovarian cancer.
    Gadducci A; Ferdeghini M; Malagnino G; Prontera C; Fanucchi A; Annicchiarico C; Bianchi R; Fioretti P; Facchini V
    Gynecol Oncol; 1994 Mar; 52(3):386-91. PubMed ID: 8157196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of soluble interleukin-2 receptor and interleukin-10 in the serum of patients with aggressive non-Hodgkin's lymphoma. Identification of a subset at high risk of treatment failure.
    Stasi R; Zinzani L; Galieni P; Lauta VM; Damasio E; Dispensa E; Dammacco F; Tura S; Papa G
    Cancer; 1994 Sep; 74(6):1792-800. PubMed ID: 8082082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum levels of soluble interleukin-2 receptors in small cell lung carcinoma.
    Yamaguchi K; Nishimura Y; Kiyokawa T; Matsuzaki H; Ishii T; Kubota K; Kawahara M; Furuse K; Yoshinaga T; Kinuwaki E
    J Lab Clin Med; 1990 Oct; 116(4):457-61. PubMed ID: 2170552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical significance of serum soluble interleukin 2 receptor (sIL-2R) concentration in lung cancer.
    Naumnik W; Chyczewska E
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():185-6. PubMed ID: 11820599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The level of soluble interleukin 2 receptor in esophageal carcinoma patients before and after radiotherapy].
    Liu X; An H; Jiang Y
    Zhonghua Zhong Liu Za Zhi; 1995 Mar; 17(2):97-9. PubMed ID: 7656815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum soluble interleukin 2 (IL-2) receptor (sIL-2R) in differentiated thyroid carcinoma.
    Mariotti S; Barbesino G; Caturegli P; Marinò M; Manetti L; Fugazzola L; Pacini F; Pinchera A
    J Endocrinol Invest; 1994 Dec; 17(11):861-7. PubMed ID: 7745234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum soluble IL-2 receptor level in patients with sarcoidosis].
    Ina Y; Takada K; Noda M; Satou T; Hashiba H; Miyachi A; Ito S; Iijima N; Yamamoto M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Mar; 29(3):316-21. PubMed ID: 2067152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated concentration of soluble interleukin-2 receptors in serum of smokers and patients with lung cancer. Correlation with clinical activity.
    Ginns LC; De Hoyos A; Brown MC; Gaumond BR
    Am Rev Respir Dis; 1990 Aug; 142(2):398-402. PubMed ID: 2200317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble interleukin-2 receptors in sera of children with primary malignant neoplasms.
    Bodey B; Psenko V; Lipsey AL; Kaiser HE
    Anticancer Res; 1996; 16(1):219-24. PubMed ID: 8615612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum soluble interleukin-2 receptor (sIL-2R) assay in cervical and endometrial cancer. Preliminary data.
    Ferdeghini M; Gadducci A; Prontera C; Marrai R; Malagnino G; Annicchiarico C; Fioretti P; Bianchi R
    Anticancer Res; 1993; 13(3):709-13. PubMed ID: 8317901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
    Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B
    Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of soluble interleukin-2 receptor in Hodgkin disease. Relationship with clinical stage, tumor burden, and treatment outcome.
    Ambrosetti A; Nadali G; Vinante F; Carlini S; Veneri D; Todeschini G; Morosato L; de Sabata D; Chilosi M; Maggi E
    Cancer; 1993 Jul; 72(1):201-6. PubMed ID: 8508408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between serum levels of soluble interleukin-2 receptor and various disease parameters in patients with squamous cell carcinoma of the esophagus.
    Oka M; Hazama S; Takahashi M; Yamamoto K; Abe T; Yoshino S; Hayashi H; Tangoku A
    Hepatogastroenterology; 1999; 46(28):2254-9. PubMed ID: 10521976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of serum soluble interleukin-2 receptor level in patients with non-Hodgkin's lymphoma].
    Shimomura Y; Tsurumi H; Sawada M; Yamada T; Hara T; Fukuno K; Goto H; Moriwaki H
    Rinsho Ketsueki; 1999 Aug; 40(8):639-45. PubMed ID: 10496038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
    Shaarawy M; Darwish NA; Abdel-Aziz O
    J Soc Gynecol Investig; 1996; 3(1):39-46. PubMed ID: 8796806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble interleukin-2 receptors in plasma cell dyscrasias.
    Takamatsu T; Yasuda N; Ohno T; Kanoh T; Uchino H; Fujii H
    Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):749-55. PubMed ID: 2618549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.